1. A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
   Shenglan Huang et al, 2021, World Journal of Surgical Oncology CrossRef
2. Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
   Mingyang Shao et al, 2023, Chinese Medical Journal CrossRef
3. MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway
   Mei Rao et al, 2019, Biology Direct CrossRef
4. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients
   Zeyu Wang et al, 2020, BioMed Research International CrossRef
5. Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection
   Alessandra Bertacco et al, 2020, Personalized Medicine CrossRef
6. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
   Wei Zhang et al, 2021, Frontiers of Medicine CrossRef
7. Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma
   Tao Wei et al, 2021, Annals of Surgical Oncology CrossRef
8. Targeted therapy for hepatocellular carcinoma
   Ao Huang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
9. Insights into Growth Factors in Liver Carcinogenesis and Regeneration: An Ongoing Debate on Minimizing Cancer Recurrence after Liver Resection
   Ana I. Álvarez-Mercado et al, 2021, Biomedicines CrossRef
10. Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis
    Kuan-Chun Hsueh et al, 2023, Current Oncology CrossRef
11. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma
    Xu Feng et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
12. Lipophagy and liver disease: New perspectives to better understanding and therapy
    Zili Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
13. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?
    Riccardo Nevola et al, 2023, Cancers CrossRef